Behavioral effects of the 2 -adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats

Author： Jolkkonen J. Puurunen K. Rantakomi S. Harkonen A. Haapalinna A. Sivenius J.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.400, Iss.2, 2000-07, pp. : 211-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effects of a specific 2 -adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats

By Haapalinna A. Sirvio J. MacDonald E. Virtanen R. Heinonen E.

European Journal of Pharmacology, Vol. 387, Iss. 2, 2000-01 ,pp. : 141-150

Elsevier

Access to resources Recommend Favorite

Neuroprotection by the 2 -adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia

By Jolkkonen J. Puurunen K. Koistinaho J. Kauppinen R. Haapalinna A. Nieminen L. Sivenius J.

European Journal of Pharmacology, Vol. 372, Iss. 1, 1999-05 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite

Atipamezole, an 2 -adrenoceptor antagonist, augments the effects of l-DOPA on evoked dopamine release in rat striatum

By Yavich L. Sirvio J. Haapalinna A. Ylinen A. Mannisto P.T.

European Journal of Pharmacology, Vol. 462, Iss. 1, 2003-02 ,pp. : 83-89

Elsevier

Access to resources Recommend Favorite

Effects of a selective 2 -adrenoceptor antagonist, atipamezole, on hypothalamic histamine and noradrenaline release in vivo

By Laitinen K.S.M. Tuomisto L. MacDonald E.

European Journal of Pharmacology, Vol. 285, Iss. 3, 1995-10 ,pp. : 255-260

Elsevier

Access to resources Recommend Favorite

Facilitation of cognitive functions by a specific 2 -adrenoceptor antagonist, atipamezole

By Haapalinna A. Sirvio J. Lammintausta R.

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 29-40

Elsevier

Access to resources Recommend Favorite